Home > Boards > Free Zone > User's Groups > Mohacsy's Safe Portfolio Member Forum

Orphan Drug Status doesn't assure FDA approval of

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
n4807g Member Profile
Member Level 
Followed By 31
Posts 26,913
Boards Moderated 0
Alias Born 07/08/03
160x600 placeholder
Imf Cuts U.s. 2014 Growth Forecast To 1.7%
The International Monetary Fund revised its growth outlook for the U.S. economy for the second time in two months after a first-quarter contraction turned out to be worse than the fund originally forecast.
More Top Equities Stories Of The Day
Crash Investigators Face Difficult Task in Ukraine
European Stocks Slip; Shire Leads FTSE Gains
Have Big-Screen Smartphones Crashed the Tablet Party?
ADR Shares End Mixed; GlaxoSmithKline Shares Trade Actively
Taiwan Export Orders Point to Stronger Global Demand
Judge Delays Decision on Argentine Bonds
U.S. Hot Stocks: Hot Stocks to Watch
Alstom Orders Double but Sales Fall
n4807g Member Level  Monday, 04/23/12 12:16:00 PM
Re: FullBoogie post# 60301
Post # of 67673 
Orphan Drug Status doesn't assure FDA approval of the compound being evaluated, it confers certain marketing advantages and tax credits should the drug be approved.

Like most small biotechs CYTR will succeed or fail on the technology they employ. In CYTR's case the delivery system. The near term future of INNO-206 will be clear when they report interim findings of their ongoing 2b trial.

Like all biotechs this is a speculative investment, but I've watched many companies with similar strategies do well. The preliminary data look promising (no guarantee) but as I said in my previous post Abraxane uses Albumin as the entry vehicle in tumors and CYTR uses the same concept.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist